Selection based on SAF activity score, not NASH CRN NAFLD activity score, leads to selection of a patient cohort with more severe NASH with more advanced fibrosis: experience from the NATIVE phase 2b study of the PanPPAR agonist lanifibranor
Year: 2020
Type: conference-paper
Authors: Francque, Sven, Bedossa, Pierre, Ratziu, Vlad, Anstee, Quentin, Bugianesi, Elisabetta, Sanyal, Arun, Loomba, Rohit, Harrison, Stephen A., Balabanska, Rozalina Ivanova, Mateva, Lyudmila, Lanthier, Nicolas
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7043171180
